Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeSales of Property, Plant and EquipmentShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Zentalis Pharmaceuticals (ZNTL) Other financing activities (2024)

Historic Other financing activities for Zentalis Pharmaceuticals (ZNTL) over the last 1 years, with Q1 2024 value amounting to $241000.0.

  • Zentalis Pharmaceuticals' Other financing activities changed N/A to $241000.0 in Q1 2024 from the same period last year, while for Sep 2024 it was $241000.0, marking a year-over-year change of. This contributed to the annual value of $18.4 million for FY2020, which is 3995217.39% up from last year.
  • Latest data reveals that Zentalis Pharmaceuticals reported Other financing activities of $241000.0 as of Q1 2024.
  • Zentalis Pharmaceuticals' 5-year Other financing activities high stood at $241000.0 for Q1 2024, and its period low was $241000.0 during Q1 2024.